[1] Liu Lixin Han Yali,.Clinical Study on the Treatment of Cardiovascular Diseases with Anxiety Disorder by Integrated Traditional Chinese and Western Medicine [J]. Modern Traditional Chinese Medicine, 2019, (04): 40-42,75. [doi: 10.13424/j.cnki.mtcm.2019.04.012]
Clinical Study on the Treatment of Cardiovascular Diseases with Anxiety Disorder by Integrated Traditional Chinese and Western Medicine
- Article number:
- 1672 -0571( 2019) 04 -0040 -04
- Keywords:
- integrated traditional Chinese and Western medicine treatment; cardiovascular disease with anxiety disorder; clinical effect
- ZTFLH:
- R254
- Code:
- B
- Abstract:
- To explore the clinical effect of integrated traditional Chinese and Western medicine in the treatment of cardiovascular diseases with anxiety disorder. Methods: 60 patients admitted from August 2016 to August 2018 with cardiovascular diseases and anxiety disorders were randomly divided into two groups: treatment group ( 30 cases treated with integrated traditional Chinese and Western medicine) and control group ( 30 cases treated with Western medicine) . Cardiac function, anxiety score and clinical efficacy of the two groups were analyzed. Results: The proportion of cardiac function grade I in the treatment group was significantly higher than that in the control group ( P < 0. 05) , the proportion of grade II and III was significantly lower than that in the control group ( P < 0. 05) , the anxiety score was significantly lower than that in the control group ( P < 0. 05) , and the total effective rate of treatment was 96. 67% ( 29/30) , significantly higher than that in the control group ( 76. 67% ( 23/30) ( P < 0. 05) . Conclusion: The clinical effect of integrated traditional Chinese and Western medicine in the treatment of cardiovascular disease with anxiety disorder isbetter than that of Western medicine alone.
References:
[1]占继贤.探讨中西医结合治疗心血管疾病伴焦虑症患者的临床疗效[J].世界最新医学信息文摘,2016,16(A0):243.
[2]杨彦征.中西医联合治疗心血管疾病合并焦虑症临床效果分析[J].中外医疗,2013,32(6):105-106.
[3]焦虑症的诊断标准和类型[J].科学大观园,2004,(10):38-38.
[4]杨戈,袁一君,张杰,等.坤泰胶囊对围绝经期轻中度焦虑症患者汉密尔顿焦虑量表因子分的影响[J].中国中医药现代远程教育,2018,16(20):104-106.
[5] Shameer K, Perez - Rodriguez MM, Bachar R, etal. Pharmacological risk factors associated with hospital readmission rates in a psychiatric cohort identified using prescriptome data mining [ J] . BMC Med Inform Decis Mak.2018;18( Suppl 3) :79.
[6]李莉.心血管疾病伴发焦虑症的临床诊治研究[J].吉林医学,2014,35(6):1142.
[7]郭江红,冯惠芳,陈小平,等.心血管住院病人伴发焦虑抑郁症状的调查研究[J].中西医结合心脑血管病杂志,2013,11(2):237-238.
[8]马永俊.中西医结合治疗心血管疾病合并焦虑症的临床分析[J].中国处方药,2015,13(12):94-95.
[9] Shameer K, Perez - Rodriguez MM, Bachar R, etal. Pharmacological risk factors associated with hospital readmission rates in a psychiatric cohort identified using prescriptome data mining [ J] . BMC Med Inform Decis Mak.2018;18( Suppl 3) :79.
[10] Bejerot S, Hesselmark E, Mobarrez F, etal. Neuromyelitis optica spectrum disorder with increased aquaporin - 4microparticles prior to autoantibodies in cerebrospinal fluid: a case report[ J] . J Med Case Rep, 2019,13( 1) :27.
Memo
收稿日期：２０１８－１０－２８ 编辑：巩振东）